Safety and Efficacy of Combined Venous Sinus Balloon Protection Technique in transarterial Embolization of Low-and intermediate-grade Transverse-Sigmoid Sinus Dural Arteriovenous Fistulas: A Cohort of 161 patients.

Huiwei Liu, Zihao Song, Xin Su, Hongqi Zhang, Ming Ye, Yongjie Ma, Peng Zhang
{"title":"Safety and Efficacy of Combined Venous Sinus Balloon Protection Technique in transarterial Embolization of Low-and intermediate-grade Transverse-Sigmoid Sinus Dural Arteriovenous Fistulas: A Cohort of 161 patients.","authors":"Huiwei Liu, Zihao Song, Xin Su, Hongqi Zhang, Ming Ye, Yongjie Ma, Peng Zhang","doi":"10.3174/ajnr.A8709","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and purpose: </strong>The venous sinus balloon protection technique is regarded as a safe and effective method for treating transverse-sigmoid sinus (TSS) dural arteriovenous fistulas (DAVFs). However, large cohort studies on this technology are still lacking. This study aims to present a large single-center experience on the safety and efficacy of venous sinus balloon protection in the treatment of TSS DAVFs.</p><p><strong>Materials and methods: </strong>We conducted a retrospective review of our database, identifying all patients with low-and intermediate-grade TSS-DAVFs who underwent transarterial embolization (TAE) between 2002 and 2020. The patients were categorized into two groups: the Venous Sinus Balloon Protection (VSBP) group and the Non-Venous Sinus Balloon Protection (NVSBP) group, based on the use of the venous sinus balloon protection technique. The safety and efficacy of the venous sinus balloon protection technique were subsequently analyzed.</p><p><strong>Results: </strong>The study included 161 patients with low-and intermediate-grade TSS-DAVFs who received TAE, comprising 72 individuals in the VSBP group and 89 in the NVSBP group. The objective of the study was to evaluate the safety and efficacy of sinus balloon protection by comparing clinical and angiographic outcomes, as well as complication rates, between the two groups. Favorable clinical outcomes were similar between the two groups (VSBP 93.1% vs. NVSBP 96.6%, P=0.501), with no statistically significant difference in the incidence of the rate of complications (VSBP 1.4% vs. NVSBP 2.2%, P=1.000). However, the rate of complete occlusion was significantly higher in the VSBP group compared to the NVSBP group (87.5% vs. 69.7%, P=0.007).</p><p><strong>Conclusions: </strong>The sinus balloon protection technique demonstrates excellent safety and effectiveness, significantly improving the complete occlusion rate of low-and intermediate-grade TSS-DAVFs in the near term, without increasing the incidence of complications. In the future, larger prospective cohorts are needed to further elucidate and confirm the safety and effectiveness of the sinus balloon protection technique for all dural arteriovenous fistulas.</p><p><strong>Abbreviations: </strong>Dural arteriovenous fistula; Transverse-sigmoid sinus; Transarterial embolization; Venous sinus balloon protection.</p>","PeriodicalId":93863,"journal":{"name":"AJNR. American journal of neuroradiology","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-02-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"AJNR. American journal of neuroradiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3174/ajnr.A8709","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background and purpose: The venous sinus balloon protection technique is regarded as a safe and effective method for treating transverse-sigmoid sinus (TSS) dural arteriovenous fistulas (DAVFs). However, large cohort studies on this technology are still lacking. This study aims to present a large single-center experience on the safety and efficacy of venous sinus balloon protection in the treatment of TSS DAVFs.

Materials and methods: We conducted a retrospective review of our database, identifying all patients with low-and intermediate-grade TSS-DAVFs who underwent transarterial embolization (TAE) between 2002 and 2020. The patients were categorized into two groups: the Venous Sinus Balloon Protection (VSBP) group and the Non-Venous Sinus Balloon Protection (NVSBP) group, based on the use of the venous sinus balloon protection technique. The safety and efficacy of the venous sinus balloon protection technique were subsequently analyzed.

Results: The study included 161 patients with low-and intermediate-grade TSS-DAVFs who received TAE, comprising 72 individuals in the VSBP group and 89 in the NVSBP group. The objective of the study was to evaluate the safety and efficacy of sinus balloon protection by comparing clinical and angiographic outcomes, as well as complication rates, between the two groups. Favorable clinical outcomes were similar between the two groups (VSBP 93.1% vs. NVSBP 96.6%, P=0.501), with no statistically significant difference in the incidence of the rate of complications (VSBP 1.4% vs. NVSBP 2.2%, P=1.000). However, the rate of complete occlusion was significantly higher in the VSBP group compared to the NVSBP group (87.5% vs. 69.7%, P=0.007).

Conclusions: The sinus balloon protection technique demonstrates excellent safety and effectiveness, significantly improving the complete occlusion rate of low-and intermediate-grade TSS-DAVFs in the near term, without increasing the incidence of complications. In the future, larger prospective cohorts are needed to further elucidate and confirm the safety and effectiveness of the sinus balloon protection technique for all dural arteriovenous fistulas.

Abbreviations: Dural arteriovenous fistula; Transverse-sigmoid sinus; Transarterial embolization; Venous sinus balloon protection.

静脉窦球囊联合保护技术经动脉栓塞治疗中低级别横乙状窦硬膜动静脉瘘的安全性和有效性:161例队列研究。
背景与目的:静脉窦球囊保护技术是治疗横乙状窦(TSS)硬膜动静脉瘘(DAVFs)的一种安全有效的方法。然而,关于该技术的大规模队列研究仍然缺乏。本研究旨在对静脉窦球囊保护治疗TSS davf的安全性和有效性进行大型单中心研究。材料和方法:我们对我们的数据库进行了回顾性审查,确定了2002年至2020年期间接受经动脉栓塞(TAE)治疗的所有中低级别tss - davf患者。根据静脉窦球囊保护技术的使用情况,将患者分为静脉窦球囊保护组(VSBP)和非静脉窦球囊保护组(NVSBP)。随后分析了静脉窦球囊保护技术的安全性和有效性。结果:本研究纳入了161例接受TAE治疗的中低级别tss - davf患者,其中VSBP组72例,NVSBP组89例。本研究的目的是通过比较两组的临床和血管造影结果以及并发症发生率来评估窦球囊保护的安全性和有效性。两组良好的临床结果相似(VSBP 93.1% vs NVSBP 96.6%, P=0.501),并发症发生率差异无统计学意义(VSBP 1.4% vs NVSBP 2.2%, P=1.000)。然而,VSBP组的完全闭塞率明显高于NVSBP组(87.5% vs. 69.7%, P=0.007)。结论:窦球囊保护技术具有良好的安全性和有效性,可在近期显著提高中低级别tss - davf的完全闭塞率,且未增加并发症的发生率。在未来,需要更大的前瞻性队列来进一步阐明和确认窦球囊保护技术对所有硬膜动静脉瘘的安全性和有效性。关键词:硬脑膜动静脉瘘;Transverse-sigmoid窦;肝动脉栓塞;静脉窦气囊保护。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信